Evidence Hub

Recurrent Subcutaneous Abscess from Co-Infection with Prototheca wickerhamii and Mycobacterium haemophilum: mNGS Misdiagnosis as Leprosy

Jiang L, Wei L, Li X, Zheng D, Cao C, Li M

Infection and drug resistance, 2025

Abstract

Prototheca wickerhamii (P. wickerhamii) and Mycobacterium haemophilum (M. haemophilum) are both opportunistic pathogens that could cause infections in immunocompromised populations. However, these infections rarely occur in individuals with normal immunity. We reported a 39-year-old immunocompetent man presented with recurrent subcutaneous abscess on fingers who developed a co-infection of P. wickerhamii and M. haemophilum. To our knowledge, this is the first reported co-infection involving P. wickerhamii and M. haemophilum. The diagnosis was complicated by mNGS misidentifying M. haemophilum as Mycobacterium leprae (M. leprae) (98% sequence similarity) and overlooking P. wickerhamii. This case underscores the critical need to correlate mNGS results with clinical features and use complementary diagnostic methods to avoid errors. The combination of traditional and molecular methods can improve diagnostic accuracy.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free